Welcome to our dedicated page for Dynatronics news (Ticker: DYNT), a resource for investors and traders seeking the latest updates and insights on Dynatronics stock.
Dynatronics Corporation (DYNT) is a medical device company that has focused on restorative products for physical therapy, rehabilitation, orthopedics, pain management, and athletic training. Company news has highlighted its role as a manufacturer serving clinical and athletic training environments, with products marketed under brands such as Bird & Cronin®, Solaris™, Hausmann®, Physician's Choice®, and PROTEAM™.
News releases for Dynatronics have covered several recurring themes. Earnings announcements and quarterly financial results provide updates on net sales, gross profit margins, operating performance, and guidance for future fiscal periods. Management commentary in these releases has discussed sales goals, operating plans, and strategic priorities, including product development and business optimization efforts.
Dynatronics’ news flow has also included product and portfolio updates, such as references to new additions to its rehabilitation furniture line, which the company associates with treatment furniture and athletic training center products. Corporate governance and leadership changes have been another focus, with announcements about board appointments and executive hires, including changes in the chief financial officer role and additions to the Board of Directors.
Trading and listing developments have been an important part of Dynatronics’ public communications. In June 2024, the company announced that it had received notice from The Nasdaq Stock Market regarding suspension of trading due to minimum bid price noncompliance and that it would transition its common stock quotation to the OTCQB Venture Market. Later, in January 2026, an 8-K reported that Dynatronics and its subsidiaries ceased operations and filed for Chapter 7 bankruptcy, marking a significant change in the company’s status.
Investors and researchers using this news page can review historical press releases and related coverage to understand Dynatronics’ business focus, financial performance, leadership changes, trading venue transition, and its subsequent Chapter 7 bankruptcy filing.
Dynatronics Corporation (NASDAQ:DYNT) announced it will release its financial results for Q1 FY2023 on November 10, 2022, before market open. A conference call will follow at 8:00 AM ET, featuring prepared remarks and a Q&A session with analysts. Participants can dial 888-506-0062 (U.S.) or 973-528-0011 (international) to join, using passcode 844024. An audio replay will be available post-call. The company specializes in medical devices for physical therapy and rehabilitation, marketing products through various established brands.
Dynatronics Corporation (NASDAQ: DYNT) reported financial results for Q4 FY '22, achieving net sales of $11.2 million, a 14% increase year-over-year, alongside a gross profit margin expansion to 23.4%. Despite a net loss of $1.6 million, the company forecasts FY '23 net sales of $45-$48 million, indicating a 5% growth. The CEO highlighted positive market reception to their new business model and anticipated improvements in cash flow as inventory is sold down. However, ongoing inflation, supply chain challenges, and pandemic impacts pose risks.
Dynatronics Corporation (NASDAQ:DYNT) announced it will release its financial results for the fourth quarter and fiscal year ended June 30, 2022, on September 22, 2022, before market opens. Following the results, management will hold a conference call at 8:00 AM ET to discuss the performance, featuring a presentation and a Q&A session. Interested participants can access the call via phone or through the company’s Investor Relations website. The call is expected to provide insights into the company's recent financial metrics and future outlook.
Dynatronics Corporation (NASDAQ:DYNT) announced a senior leadership reorganization aimed at boosting sales growth and profitability. CEO John Krier will also serve as Chief Financial Officer, taking on responsibilities previously held by Norm Roegner, who is departing the company. Mike Withers, with extensive IT experience, is appointed as the new Chief Information Officer, filling a vacancy since 2020. These strategic changes are intended to streamline operations and align IT systems with business goals, enhancing revenue growth for the company.
Dynatronics Corporation (NASDAQ:DYNT) reported its Q3 FY '22 results, highlighting a net sales of $10.3 million and a gross profit margin increase to 22.4%. Despite a net loss of $1.5 million, the company anticipates a 16% sales growth for Q4, projecting total FY '22 sales between $44 million and $45 million, approximately a 20% increase from the previous year. The firm continues to face challenges due to COVID-19 but remains focused on market share expansion and product innovations, targeting gross margins above 40% over time.
Dynatronics Corporation (NASDAQ:DYNT) announces the release of its financial results for the fiscal third quarter ended March 31, 2022, set for May 12, 2022, before market opening. Following the announcement, a conference call will occur at 10:00 AM ET, featuring management remarks, a slide presentation, and a Q&A session with analysts. Participants can join via a dedicated phone line or through a provided webcast link. The event aims to provide insights into the company's performance and strategic outlook for investors.
EAGAN, MN / ACCESSWIRE / March 24, 2022 / Dynatronics Corporation (NASDAQ:DYNT) announced its participation in Maxim Group's 2022 Virtual Growth Conference. The management's on-demand webcast for investors will be available on March 28, 2022, on the company's Investor Relations website. This conference, hosted by M-Vest, runs from March 28-30, 2022, from 9:00 a.m. to 5:00 p.m. EDT. Dynatronics specializes in manufacturing a range of medical devices for physical therapy, rehabilitation, and athletic training, marketing products under well-known brands.
Dynatronics Corporation (NASDAQ:DYNT) announced its participation in two upcoming investor conferences: the Roth Capital Conference on March 14, 2022, and the Maxim Group Virtual Growth Conference on March 28-29, 2022. CEO John Krier will provide updates and engage in one-on-one meetings at these events. A virtual on-demand presentation and a live fireside chat will be available for investors during the Roth event, with archived access on the company's investor webpage. Dynatronics focuses on high-quality restorative products for physical therapy and rehabilitation.
Dynatronics Corporation (NASDAQ:DYNT) reported Q2 FY '22 financial results, achieving total net sales of $10.5 million but incurring a net loss of $1.4 million. The company maintains confidence in its outlook, expecting net sales for FY '22 to range between $40 million and $45 million, up 15% from previous benchmarks. COVID-19 continues to pose challenges, including increased costs and supply chain issues. The focus remains on business transformation, new product launches, and enhancing operational efficiency to drive sustainable growth.
Dynatronics Corporation (NASDAQ:DYNT) will release its fiscal second quarter results for the period ended December 31, 2021, on February 10, 2022, before market opening. A conference call and webcast will follow at 10:00 AM ET that same day, including management's remarks, a slide presentation, and a Q&A session. Access details include dialing 888-506-0062 for U.S./Canada participants or 973-528-0011 for international callers. The live webcast will be available on the company's Investor Relations website, with an archive for future viewing.
FAQ
What is the current stock price of Dynatronics (DYNT)?
What is the market cap of Dynatronics (DYNT)?
